Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Pavel Dřevínek"'
Autor:
Barry J Plant, Daniel Peckham, Pierre-Régis Burgel, Alan Smyth, Andreas Jung, Manfred Ballmann, Giovanni Taccetti, Harry Heijerman, Pavel Drevinek, Jochen G Mainz, Carsten Schwarz
Publikováno v:
BMJ Open Respiratory Research, Vol 11, Iss 1 (2024)
The major cause of mortality in people with cystic fibrosis (pwCF) is progressive lung disease characterised by acute and chronic infections, the accumulation of mucus, airway inflammation, structural damage and pulmonary exacerbations. The prevalenc
Externí odkaz:
https://doaj.org/article/ce777e645bdb4ad08771fda0a6783f30
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 6 (2023)
Externí odkaz:
https://doaj.org/article/dd27bbd809a74b1e9d927dd648fde12b
Publikováno v:
Diagnostics, Vol 14, Iss 6, p 631 (2024)
This review aims to explore the role of professional diagnostic rapid testing of acute respiratory infections (ARIs), especially COVID-19 and influenza, ensuring proper disease management and treatment in Europe, and particularly in Czech Republic, P
Externí odkaz:
https://doaj.org/article/137fdf8839e54f6294086352254e1686
Autor:
Marcela Krutova, Vaclav Capek, Elka Nycova, Sabina Vojackova, Magda Balejova, Lenka Geigerova, Renata Tejkalova, Lenka Havlinova, Iva Vagnerova, Pavel Cermak, Lenka Ryskova, Petr Jezek, Dana Zamazalova, Denisa Vesela, Alice Kucharova, Dana Nemcova, Martina Curdova, Otakar Nyc, Pavel Drevinek
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 9, Iss 1, Pp 1-7 (2020)
Abstract Objectives To investigate the relationship between Clostridium (Clostridioides) difficile strain characteristics and C. difficile infection (CDI) outcome. Methods Between October and December 2017, 16 hospitals collected epidemiological data
Externí odkaz:
https://doaj.org/article/bfccef46c1c44ebe97af5cf581c33e3c
Autor:
Andreas Jung, Annalisa Orenti, Fiona Dunlevy, Elina Aleksejeva, Egil Bakkeheim, Vladimir Bobrovnichy, Siobhán B. Carr, Carla Colombo, Harriet Corvol, Rebecca Cosgriff, Géraldine Daneau, Deniz Dogru, Pavel Drevinek, Andrea Dugac Vukic, Isabelle Fajac, Alice Fox, Stojka Fustik, Vincent Gulmans, Satenik Harutyunyan, Elpis Hatziagorou, Irena Kasmi, Hana Kayserová, Elena Kondratyeva, Uroš Krivec, Halyna Makukh, Kestutis Malakauskas, Edward F. McKone, Meir Mei-Zahav, Isabelle de Monestrol, Hanne Vebert Olesen, Rita Padoan, Tsitsino Parulava, Maria Dolores Pastor-Vivero, Luísa Pereira, Guergana Petrova, Andreas Pfleger, Liviu Pop, Jacqui G. van Rens, Milan Rodic´, Marc Schlesser, Valérie Storms, Oxana Turcu, Lukasz Woz´niacki, Panayiotis Yiallouros, Anna Zolin, Damian G. Downey, Lutz Naehrlich
Publikováno v:
ERJ Open Research, Vol 7, Iss 4 (2021)
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in people with cystic fibrosis (pwCF) can lead to severe outcomes. Methods In this observational study, the European Cystic Fibrosis Society Patient Registry collected
Externí odkaz:
https://doaj.org/article/3e2becbd44ec4bf582d17021b6083a88
Autor:
Jan Tkadlec, Eliska Bebrova, Jan Berousek, Tomas Vymazal, Jaroslava Adamkova, Vendula Martinkova, Claus Moser, Dragos Florea, Pavel Drevinek
Publikováno v:
MicrobiologyOpen, Vol 9, Iss 5, Pp n/a-n/a (2020)
Abstract Fast and accurate detection of causative agents of bloodstream infections remains a challenge of today's microbiology. We compared the performance of cutting‐edge technology based on polymerase chain reaction coupled with electrospray ioni
Externí odkaz:
https://doaj.org/article/3554bc889f154982be7d00ef3c055237
Autor:
Lucia Karnisova, Monika Marejkova, Hana Hrbackova, Alexander Mellmann, Helge Karch, Angelika Fruth, Pavel Drevinek, Kveta Blahova, Martina Bielaszewska, Jaroslav Nunvar
Publikováno v:
BMC Genomics, Vol 19, Iss 1, Pp 1-12 (2018)
Abstract Background Enterohemorrhagic Escherichia coli (EHEC) O26:H11/H−, the most common non-O157 serotype causing hemolytic uremic syndrome worldwide, are evolutionarily highly dynamic with new pathogenic clones emerging rapidly. Here, we investi
Externí odkaz:
https://doaj.org/article/ff292ad9a6894a99a347e780c8802e20
Autor:
Libor Fila, Lucie Valentova Bartakova, Alzbeta Grandcourtova, Miloslav Marel, Radovan Drnek, Alena Bilkova, Milan Macek, Pavel Drevinek
Publikováno v:
Biomedical Papers, Vol 160, Iss 2, Pp 276-279 (2016)
Aims: Ivacaftor is a revolutionary treatment option for cystic fibrosis (CF) patients with G551D and other gating mutations. The aim of this study was to evaluate the clinical status of patients on ivacaftor who were followed for up to 6 years togeth
Externí odkaz:
https://doaj.org/article/227fe668bf8c4b7285e574094b698726
Publikováno v:
PLoS Pathogens, Vol 13, Iss 12, p e1006762 (2017)
Burkholderia cenocepacia causes severe pulmonary infections in cystic fibrosis (CF) patients. Since the bacterium is virtually untreatable by antibiotics, chronic infections persist for years and might develop into fatal septic pneumonia (cepacia syn
Externí odkaz:
https://doaj.org/article/a3fb40c43d8a4887863252daffb1c7f0
Autor:
Jaroslav Nunvar, Andrew M. Hogan, Silvia Buroni, Svetlana Savina, Vadim Makarov, Silvia T. Cardona, Pavel Drevinek
Publikováno v:
Antibiotics, Vol 8, Iss 4, p 159 (2019)
Bacteria of the Burkholderia cepacia complex (Bcc) are associated with significant decline of lung functions in cystic fibrosis patients. Bcc infections are virtually impossible to eradicate due to their irresponsiveness to antibiotics. The 2-thiocya
Externí odkaz:
https://doaj.org/article/6052ffe320b6418ca17e1a26f7476200